Core Points - The European Medicines Agency (EMA) has initiated a review of Valneva's chikungunya vaccine IXCHIQ due to reports of serious adverse events (SAEs) in elderly individuals, leading to a temporary suspension of its use for those over 65 years old [1][2] - A total of 17 SAEs, including two deaths, have been reported globally among elderly individuals with significant underlying medical conditions [2] - The exact cause of these SAEs and their relationship to the vaccine remain undetermined, and healthcare professionals are reminded not to administer IXCHIQ to individuals with weakened immune systems [3] Company Overview - Valneva SE is a specialty vaccine company focused on developing, manufacturing, and commercializing vaccines for infectious diseases, addressing unmet medical needs [9] - The company has a strong track record of advancing multiple vaccines from early research and development to approvals, currently marketing three proprietary travel vaccines [10] - Valneva is also developing vaccine candidates for Lyme disease, Zika virus, and other global public health threats [10] Industry Context - Chikungunya virus (CHIKV) is a mosquito-borne disease that has been identified in over 110 countries, with significant economic and medical burdens expected to grow due to climate change [8] - Between 2013 and 2023, more than 3.7 million chikungunya cases were reported in the Americas, highlighting the disease as a major public health concern [8]

Core Viewpoint - Klépierre, a leading European shopping mall operator, has reported its total number of shares and voting rights as of April 30, 2025, while also outlining its upcoming dividend payment schedule and emphasizing its commitment to sustainable development [2][3][4]. Company Information - Klépierre is the European leader in shopping malls, focusing exclusively on continental Europe, with a portfolio valued at €20.2 billion as of December 31, 2024 [4]. - The company operates large shopping centers across more than 10 countries in Continental Europe, attracting over 700 million visitors annually [4]. - Klépierre is a French REIT (SIIC) listed on Euronext Paris and is included in various indexes, including CAC Next 20 and EPRA Euro Zone Indexes, as well as ethical indexes like Euronext CAC 40 ESG and MSCI Europe ESG Leaders [4]. Voting Rights and Shares - As of April 30, 2025, Klépierre has a total of 286,861,172 shares, with 285,864,980 exercisable voting rights [2][6][7]. - The theoretical voting rights correspond to the total number of voting rights attached to all shares, including those deprived of voting rights [6]. Dividend Payment Schedule - The ex-dividend date for the final dividend payment is set for July 8, 2025, with the record date on July 9, 2025, and the final dividend payment scheduled for July 10, 2025 [3].

Core Points - COFACE SA has published its Solvency and Financial Condition Report (SFCR) for the financial year 2024, in compliance with Solvency II requirements [1][7] - The report was approved by the Board of Directors and is produced annually [1] - The Group's eligible own funds to cover the Solvency Capital Requirement (SCR) amounted to €2,630 million, with a coverage ratio of 196%, exceeding the target range of 155% - 175% [7] - The Compagnie's SCR coverage ratio was reported at 237% [7] - The Group plans to distribute 80% of its net profit for 2024, proposing a dividend of €1.40 per share, subject to shareholder approval [7][11] Financial Information - COFACE SA registered a turnover of €1.84 billion in 2024 and employed approximately 5,236 people [9] - The financial calendar for 2025 includes the Annual General Shareholders' Meeting on 14 May 2025 and the H1-2025 results on 31 July 2025 [4] Regulatory Compliance - The SFCR is part of the regulatory framework established by the Solvency II Directive, which includes requirements for narrative reports for regulators and the public [11]

Core Viewpoint - TOUAX SCA proposes to transfer its listing from Euronext Paris to Euronext Growth Paris to better align with its size and operational needs while reducing regulatory constraints and costs [2][3]. Group 1: Transfer Proposal - The transfer will be voted on at the Combined General Meeting scheduled for June 12, 2025, with the aim of delisting from Euronext Paris and being admitted to Euronext Growth Paris [1]. - The company currently meets the Euronext Growth market requirements, including a market capitalization of less than one billion euros and a free float of at least 2.5 million euros [3]. Group 2: Regulatory and Reporting Changes - Euronext Growth is an organized multilateral trading facility with less stringent regulations compared to a regulated market [4]. - The company will continue to publish an annual report within four months of the financial year-end, but the management report and corporate governance report will have simplified disclosure requirements [5]. - A half-yearly report will be published within four months of the half-year closing, with the three-month publication deadline extended by one month on Euronext Growth [6]. Group 3: Ongoing Information and Governance - The company will still disclose any information that could significantly impact its share price and will adhere to the Market Abuse Regulation [8]. - Senior executives will continue to declare transactions involving the company's shares [9]. - The company will not be required to post voting results and minutes on its website, but transparency regarding the remuneration of Managing Partners will still be maintained [11]. Group 4: Shareholder Obligations and Liquidity - Shareholders will need to declare their intention to acquire shares for three years post-listing on Euronext Growth, with specific reporting requirements for crossing certain ownership thresholds [13][14]. - The liquidity contract will remain in place after the market transfer [15]. Group 5: Indicative Timetable - The indicative timetable for the transfer includes key dates such as the Combined General Meeting on June 12, 2025, and potential delisting from Euronext by August 13, 2025 [18]. Group 6: Company Overview - TOUAX Group manages nearly 1.3 billion euros in assets and is a leading leasing company in Europe for tangible assets like freight wagons, river barges, and containers [19].

Core Points - International Petroleum Corporation (IPC) held its 2025 Annual General Meeting of Shareholders on May 7, 2025, in Calgary, Alberta [1] - The number of Directors was set at eight [2] - All eight nominees were elected as Directors, with voting results showing a high level of support [4] Voting Results - Total votes for the election of Directors were 62,055,815, representing 99.98% approval, with only 10,847 votes against [3] - Individual nominee voting results included: - C. Ashley Heppenstall: 60,675,041 votes for (97.76%) [5] - William Lundin: 61,771,676 votes for (99.52%) [5] - Chris Bruijnzeels: 55,217,620 votes for (88.97%) [5] - Donald Charter: 61,638,931 votes for (99.31%) [5] - Lukas H. (Harry) Lundin: 61,665,996 votes for (99.35%) [5] - Emily Moore: 61,832,709 votes for (99.62%) [5] - Mike Nicholson: 61,665,366 votes for (99.35%) [5] - Deborah Starkman: 61,673,369 votes for (99.37%) [5] Auditor Appointment - PricewaterhouseCoopers LLP was appointed as the auditor of the Corporation until the next annual meeting, with the Directors authorized to fix the auditor's remuneration [6] - Votes for the auditor appointment totaled 62,220,145, representing 99.98% approval, with 12,337 votes withheld [7] Company Overview - IPC is an international oil and gas exploration and production company with assets in Canada, Malaysia, and Europe, providing a foundation for growth [7]

Core Points - The Shareholders' Meeting of Capgemini SE on May 7, 2025, approved all resolutions proposed by the Board of Directors, including a dividend distribution of €3.40 per share for the 2024 financial year, payable from May 22, 2025 [2][6] - The meeting also saw the renewal of terms for independent directors Patrick Pouyanné and Kurt Sievers, and the appointment of Jean-Marc Chéry as a new board member for a four-year term [3][4] - The Board of Directors now consists of 15 members, with 83% being independent directors, 40% international directors, and 42% women [5][10] Financial and Governance Highlights - The compensation components for Paul Hermelin, Chairman, and Aiman Ezzat, CEO, for 2024 were approved, along with the report on corporate officer compensation and 2025 compensation policies [6] - The amendment of the Company's bylaws and financial delegations to the Board of Directors were also approved during the meeting [7] Company Overview - Capgemini is a global business and technology transformation partner with 340,000 team members across more than 50 countries, reporting global revenues of €22.1 billion for 2024 [8]

Group 1 - International Petroleum Corporation (IPC) held its 2025 Annual General Meeting of Shareholders on May 7, 2025, in Calgary, Alberta, where voting results were announced [1] - The number of Directors of the Corporation was set at eight [2] - The eight nominees were elected as Directors to hold office until the next annual meeting or until their successors are duly elected or appointed [4] Group 2 - The voting results for the election of Directors showed a high level of support, with the majority receiving over 97% of votes in favor [3][5] - PricewaterhouseCoopers LLP was appointed as the auditor of the Corporation until the next annual meeting, with the Directors authorized to fix the auditor's remuneration [6] - The Corporation is an international oil and gas exploration and production company with assets located in Canada, Malaysia, and Europe, providing a solid foundation for growth [7]

Core Insights - The company reported a 3.9% increase in organic growth for Q1 2025, driven by cloud, digital, and data activities [3] - Revenues for Q1 2025 reached €214.1 million, reflecting a 4.5% growth compared to Q1 2024 [2] - Operating profit accounted for 8.2% of revenues, with an increase in taxation impacting expenses by €1 million [3] Financial Performance - Q1 2024 revenues were €204.9 million, while Q1 2025 revenues increased to €214.1 million, marking a growth of €9.2 million [2] - The organic growth component of the revenue increase was 3.9%, indicating strong underlying performance [2][3] - The operating profit margin for the quarter was 8.2%, with a noted increase in taxation affecting the overall profit [3] Future Outlook - The company has provided forecasts for the full financial year 2025, with expected revenues between €840 million and €850 million and operating profit between 8.5% and 9% of revenues [5][8] - These forecasts are subject to adjustment based on the revenue results for the first half of the year [5] Company Overview - NEURONES employs 7,250 experts and is recognized as a leader in management consulting and digital services in France [6] - The company focuses on assisting large organizations in transitioning to a digital and sustainable economy [6]

Core Viewpoint - Kvika banki hf. reported strong financial performance in Q1 2025, with significant increases in net interest income and post-tax profit, despite some challenges in fee and commission income [5][7][11]. Financial Performance - Post-tax profit for Q1 2025 was ISK 2,086 million, a 92.6% increase from ISK 1,083 million in Q1 2024 [7]. - Pre-tax profit from continuing operations, adjusted for non-recurring items, was ISK 1,590 million, up 31% from ISK 1,215 million in Q1 2024 [7]. - Net interest income rose to ISK 2,917 million, reflecting a 25.4% increase from ISK 2,326 million in Q1 2024 [7]. - Net interest margin improved to 4.4% in Q1 2025 from 3.8% in Q1 2024, attributed to strong liquidity and a growing loan book [7]. - Earnings per share increased to ISK 0.45 in Q1 2025, compared to ISK 0.23 in Q1 2024 [7]. Balance Sheet Highlights - Customer deposits increased to ISK 168 billion, a 2.8% rise from ISK 163 billion at year-end 2024 [8]. - Loans to customers grew to ISK 161 billion, marking a 6.9% increase from ISK 150 billion at year-end 2024 [8]. - Total assets decreased to ISK 343 billion, down 3.4% from ISK 355 billion at year-end 2024 [8]. - Total equity was ISK 68 billion, significantly reduced due to the sale of TM, with a capital adequacy ratio of 23.9% [8]. Strategic Developments - The successful sale of TM tryggingar hf. to Landsbankinn resulted in over ISK 32 billion returned to shareholders through dividends and share buybacks [6]. - The acquisition of the remaining management stake in Ortus Secured Finance was completed, enhancing the bank's UK operations and growth potential [9]. - The bank's infrastructure has been adapted post-TM sale, positioning it for continued growth in both Iceland and the UK [13]. Operational Insights - Administrative expenses rose to ISK 3,090 million, a 15.9% increase from ISK 2,666 million in Q1 2024, but adjusted operating expenses were lower at ISK 2,865 million [7][12]. - Fee and commission income decreased to ISK 1,520 million, down 6.9% from ISK 1,633 million in Q1 2024, reflecting challenging market conditions [7][12]. - The bank's liquidity coverage ratio was 279%, down from 360% at year-end 2024, indicating a shift in liquidity management following the TM sale [8].

Trading statement for Q3 2024/25 (1 January - 31 March 2025) Continued growth in revenue and operating profit Revenue was up by 26% in the third quarter of 2024/25 to DKK 124.2 million from DKK 98.9 million in the year-earlier period. Growth was driven primarily by sales of products related to the NC platform, reflecting increased activity levels for customers with ongoing clinical trials and approved therapies. The Q3 performance reflected continued growth in sales of both instruments, consumables and serv ...